Suppr超能文献

功能性二尖瓣反流的医学治疗。

Medical Therapy for Functional Mitral Regurgitation.

机构信息

Department of Cardiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (A.M., U.P.J.).

Department of Cardiology, Tel-Aviv Sourasky Medical Center (affiliated with the Sackler School of Medicine), Tel-Aviv University, Israel (A.M., Y.T.).

出版信息

Circ Heart Fail. 2022 Sep;15(9):e009689. doi: 10.1161/CIRCHEARTFAILURE.122.009689. Epub 2022 Jul 13.

Abstract

Functional mitral regurgitation (FMR) can be broadly categorized into 2 main groups: ventricular and atrial, which often coexist. The former is secondary to left ventricular remodeling usually in the setting of heart failure with reduced ejection fraction or less frequently due to ischemic papillary muscle remodeling. Atrial FMR develops due to atrial and annular dilatation related to atrial fibrillation/flutter or from increased atrial pressures in the setting of heart failure with preserved ejection fraction. Guideline-directed medical therapy is the first step and prevails as the mainstay in the treatment of FMR. In this review, we address the medical therapeutic options for FMR management and highlight a targeted approach for each FMR category. We further address important clinical and echocardiographic characteristics to aid in determining when medical therapy is expected to have a low yield and an appropriate window for effective interventional approaches exists.

摘要

功能性二尖瓣反流(FMR)可广泛分为 2 大主要类型:心室型和心房型,这两种类型通常并存。前者继发于左心室重构,通常发生在射血分数降低的心力衰竭中,或因缺血性乳头肌重构而较少发生。心房型 FMR 是由于心房和环扩张引起的,与心房颤动/扑动有关,或因射血分数保留的心力衰竭时心房压力增加而引起。指南指导的药物治疗是第一步,也是 FMR 治疗的主要方法。在这篇综述中,我们讨论了 FMR 管理的药物治疗选择,并强调了针对每种 FMR 类型的靶向方法。我们进一步讨论了重要的临床和超声心动图特征,以帮助确定何时药物治疗的效果预期不佳,以及何时存在有效的介入治疗方法的适当窗口。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验